Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit

Transplant Infectious Disease

Volumn 15, Issue 2, 2013, Pages 142-149

  Cumpston, A ^a   Craig, M ^a   Hamadani, M ^a   Abraham, J ^a   Hobbs, G R ^a   Sarwari, A R ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic cycling; Bacterial resistance; Hematopoietic cell transplantation; Leukemia; Neutropenic fever

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; FLUCONAZOLE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; QUINOLONE DERIVATIVE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; CELL TRANSPLANTATION; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE; COHORT ANALYSIS; DIARRHEA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GRAM NEGATIVE SEPSIS; HEALTH CENTER; HEALTH PROGRAM; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PSEUDOMONAS; RETROSPECTIVE STUDY; STENOTROPHOMONAS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MICROBIAL; FEMALE; FEVER; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NEUTROPENIA; PROSPECTIVE STUDIES;

EID: 84875931709     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12035     Document Type: Article

References (14)

1. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: e56-e93.
2. Schimpff S, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284: 1061-1065.
3. Depauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP. Ceftazidime compared to piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 1994; 120: 834-844.
4. Biron P, Fuhrmann C, Cure H, et al. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. J Antimicrob Chemother 1998; 42: 511-518.
5. Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D. Clinical experience with single agent and combination regimens in management of infection in the febrile neutropenic patient. Am J Med 1996; 100: 83S-89S.
6. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance; guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18: 275-291.
7. Craig M, Cumpston A, Hobbs GR, DeVetten MP, Sarwari AR, Ericson SG. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplant 2007; 39: 477-482.
8. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Once daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997; 39: 677-686.
9. Polk RE. Measuring antibiotic prescribing and bacterial resistance. Chapter 15. In: Wenzel R, ed. Prevention and Control of Nosocomial Infections. Philadelphia: Lippincott, Williams & Wilkins, 2003: 152-165.
10. Gerding DN. Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol 2000; 21 (Suppl): S12-S17.
11. John JF Jr, Rice LB. The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol 2000; 21 (Suppl): S22-S31.
12. Masterson RG. Antibiotic cycling: more than it might seem. J Antimicrob Chemother 2005; 55: 1-5.
13. Brown EM, Nathwani D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 2005; 55: 6-9.
14. Cadena J, Taboada CA, Burgess DS, et al. Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit. Bone Marrow Transplant 2007; 40: 151-155.